Informing Decisions,
Improving Care
OncoMark CEO Mr. Des O’Leary and OncoMark Business Development Manager Mr. Fergus Fleming are attending the Arab Health Exhibition and Congress at the Dubai International Convention and Exhibition Centre from the 29th January to the 1st February 2018.
OncoMark have initiated clinical validation of the OncoMasTR test using tumour samples from the TransATAC Tissue Resource.
OncoMark are pleased to announce the launch of their newly designed website www.oncomark.com. The website provides an enhanced user experience to our target audience to access information relating to OncoMark and the OncoMasTR test.
Study gives new hope of targeted treatment for triple negative breast cancer
Research led by Prof. William Gallagher, Director of BREAST-PREDICT and Chief Scientific Officer of OncoMark, has found a potential new approach to treating one of the most difficult-to-treat forms of breast cancer, which currently has limited treatment options.
OncoMark CEO Des O'Leary was awarded an Ireland's Champions of EU Research award from Enterprise Ireland at an event held in the Royal Hospital Kilmainham yesterday (Wednesday 28th June 2017).
OncoMark researchers have recently had a review published in the American Association for Cancer Research (AACR) journal, Cancer Research, describing how the reverse engineering of transcriptional networks using gene expression data enables the identification of genes that underpin the development and progression of different cancers.
Congratulations to Professor William Gallagher, who was the inaugural recipient of the Irish Association of Cancer Research (IACR) Cancer Research Medal at the annual IACR Conference held in Kilkenny on 22nd-24th February 2017.
OncoMasTR test to launch in 2018 and will reduce the number of patients receiving unnecessary chemotherapy